<DOC>
	<DOCNO>NCT00736502</DOCNO>
	<brief_summary>The aim trial evaluate safety virological immunological efficacy ViramuneÂ® background different antiretroviral drug combination .</brief_summary>
	<brief_title>PMS Assessing Long-term Efficacy Safety Nevirapine Therapy ( Combined With Other ARV Drugs ) HIV-1 Positive Patients Daily Clinical Practice .</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion criterion : The inclusion criterion follow criterion describe new SPC . Exclusion criterion : The exclusion criterion follow criterion describe new SPC .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>